| | ImClone Systems initiates enrollment for Phase II breast cancer trial - Pharmaceutical Business Review

ImClone Systems initiates enrollment for Phase II breast cancer trial - Pharmaceutical Business Review

ImClone Systems initiates enrollment for Phase II breast cancer trial Pharmaceutical Business Review - 7 hours ago This study is being conducted by the North Central Cancer Treatment Group (NCCTG), a national clinical research group sponsored by the National Cancer ...

Click Here to read the entire article...